Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 3
1968 1
1969 1
1970 3
1971 6
1972 2
1973 2
1974 1
1975 2
1976 2
1977 4
1978 4
1979 10
1980 5
1981 4
1982 6
1983 6
1984 9
1985 10
1986 7
1987 12
1988 9
1989 12
1990 7
1991 9
1992 9
1993 11
1994 4
1995 10
1996 6
1997 1
1998 3
1999 4
2000 2
2001 2
2002 3
2003 1
2004 1
2005 2
2006 4
2007 4
2008 6
2009 4
2010 2
2011 2
2012 1
2013 2
2014 2
2017 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators. Hochhaus A, et al. N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324. N Engl J Med. 2017. PMID: 28273028 Free PMC article. Clinical Trial.
Recent advances in myelodysplastic syndromes.
Shadduck RK, Latsko JM, Rossetti JM, Haq B, Abdulhaq H. Shadduck RK, et al. Exp Hematol. 2007 Apr;35(4 Suppl 1):137-43. doi: 10.1016/j.exphem.2007.01.022. Exp Hematol. 2007. PMID: 17379099 Free article. Review.
Treatment of myelodysplastic syndromes with 5-azacytidine.
Gryn J, Zeigler ZR, Shadduck RK, Lister J, Raymond JM, Sbeitan I, Srodes C, Meisner D, Evans C. Gryn J, et al. Among authors: shadduck rk. Leuk Res. 2002 Oct;26(10):893-7. doi: 10.1016/s0145-2126(02)00028-0. Leuk Res. 2002. PMID: 12163049
Immunosuppressive therapy.
Winkelstein A, Segel D, Stolzer BL, Fogel M, Shadduck RK, Lewis M. Winkelstein A, et al. Among authors: shadduck rk. Am J Med Sci. 1973 Feb;265(2):92-108. Am J Med Sci. 1973. PMID: 4736193 No abstract available.
Clearance of erythrocyte allo-antibodies using Rituximab.
Gryn J, Zeigler ZR, Shadduck RK, Thomas C. Gryn J, et al. Among authors: shadduck rk. Bone Marrow Transplant. 2002 Apr;29(7):631-2. doi: 10.1038/sj.bmt.1703537. Bone Marrow Transplant. 2002. PMID: 11979318 No abstract available.
Activity of azacitidine in chronic myelomonocytic leukemia.
Costa R, Abdulhaq H, Haq B, Shadduck RK, Latsko J, Zenati M, Atem FD, Rossetti JM, Sahovic EA, Lister J. Costa R, et al. Among authors: shadduck rk. Cancer. 2011 Jun 15;117(12):2690-6. doi: 10.1002/cncr.25759. Epub 2010 Dec 23. Cancer. 2011. PMID: 21656746 Free article.
218 results